Improved SARS (severe acute respiratory syndrome) diagnostic on the way
This article was originally published in Clinica
Executive Summary
A "hand made" test developed to help monitor the global spread of severe acute respiratory syndrome (SARS) is producing reliable results, while a more sophisticated test will be available "within weeks" for wider diagnostic use, says the World Health Organization. While work continues "at breakneck speed" to definitively identify the causative agent, chest X-rays are currently the main tool for distinguishing probable from suspected cases.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.